Real World Performance of SARS-CoV-2 Antigen Rapid Diagnostic Tests in Various Clinical Settings.

Regev-Yochay, Gili; Kriger, Or; Mina, Michael J; Beni, Sharon; Rubin, Carmit; Mechnik, Bella; Hason, Sabrina; Biber, Elad; Nadaf, Bian; Kreiss, Yitshak; Amit, Sharon

Regev-Yochay, Gili; Kriger, Or; Mina, Michael J; Beni, Sharon; Rubin, Carmit; Mechnik, Bella; Hason, Sabrina; Biber, Elad; Nadaf, Bian; Kreiss, Yitshak; Amit, Sharon.

Afiliação

Regev-Yochay G; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Kriger O; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.
Mina MJ; Clinical Microbiology, Sheba Medical Center, Ramat-Gan, Israel.
Beni S; Harvard Chan School of Public Health, Harvard, Boston, MA, USA.
Rubin C; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Mechnik B; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Hason S; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Biber E; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Nadaf B; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Kreiss Y; Infection Prevention & Control Unit, Sheba Medical Center, Ramat-Gan, Israel.
Amit S; Sackler School of Medicine, Tel Aviv University, Tel-Aviv, Israel.

Infect Control Hosp Epidemiol ; : 1-20, 2022 Mar 02.

Article em En | MEDLINE | ID: mdl-35232504

Palavras-chave

Antigen rapid diagnostic tests; SARS-CoV-2; positive percent agreement; sensitivity; testing strategy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google